Found 45 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer PHASE2 This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Pluvicto Real-world Investigation in Survival in Metastatic CRPC N/A This study aims to evaluate the various aspects of treatment effectiveness ...
Show More Location
Multiple Locations
Learn More & Join Trial
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer PHASE1 The goal of this clinical trial is to is to investigate if it is possible t...
Show More Location
University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer PHASE1 This phase I trial studies the safety, side effects, and treatment cycle 1 ...
Show More Location
University of Michigan Rogel Cancer Center
Learn More & Join Trial
A Study of 177Lu-PSMA-617 in People With Gliomas PHASE1 The researchers are doing this study to find out whether the radiopharmaceu...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer PHASE2 177Lu PSMA 617 is a new type of therapy which is designed to deliver high d...
Show More Status
Active Not Recruiting
Location
Tom Baker Cancer Centre
Learn More & Join Trial
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy PHASE2 The aim of this study is to assess the progression free survival (PFS) of S...
Show More Location
Royal North Shore
Learn More & Join Trial